US Stock MarketDetailed Quotes

AZTR Azitra

Watchlist

0.497
+0.012+2.37%

Close Nov 4 16:00 ET

0.509
+0.012+2.39%

Post 20:01 ET

3.79MMarket Cap-47P/E (TTM)

Azitra Stock Forum

Slooms

Oct 29 10:40

$Azitra (AZTR.US)$ Keep at it 👏
Azitra to Present at BIO-Europe 2024

far008

Oct 22 12:57

$Bright Minds Biosciences (DRUG.US)$ $AMTD Digital (HKD.US)$ these following tickers can move just with volume - no real walls $Wang & Lee Group (WLGS.US)$ $Azitra (AZTR.US)$

far008

Oct 18 23:01

ATR-04

$Azitra (AZTR.US)$ has significant developments expected soon. They plan to present new data on their clinical programs, including ATR-12 (for Netherton syndrome) and ATR-04 (targeting rashes caused by EGFR inhibitors) by late 2024 and early 2025, respectively. The FDA recently granted Fast Track Designation to ATR-04, which could accelerate its development and review process.
The probability of a product reaching the market depends on the success of their clinical trials. ATR-12 is in Pha...

far008

Oct 18 13:36

$Azitra (AZTR.US)$ nice chart move moment. Let's see a push into power hour!!!

far008

Oct 17 12:55

Azitra, Inc. is advancing several key projects in its pipeline

$Azitra (AZTR.US)$ :
1. ATR-12: This is being developed to treat Netherton syndrome, a rare skin condition with no current FDA-approved treatment. Initial safety data from a 12-patient trial is expected by late 2024, which will mark a crucial step in its clinical progression.
2. ATR-04: Targeting skin rashes associated with EGFR inhibitors (commonly used in cancer therapies), the IND submission is planned for mid-2024. The first-in-hum...